SARS-CoV-2 variant B.1.617 brought disaster to the immune system!

The new coronavirus is still a major challenge facing mankind

Researchers from the German Primate Center (DPZ) Leibniz Primate Institute studied the B.

The spike protein is embedded in the virus envelope and helps SARS-CoV-2 to enter the host cell

A team led by Markus Hoffmann, an infection researcher at the German Primate Center, studied how mutations affect the ability of B.

First, the researchers analyzed the B.

The researchers also investigated the efficacy of four different therapeutic antibodies, which have been approved for the treatment of COVID-19 patients

In the third step, the scientists tested the effectiveness of antibodies in the blood of individuals who have recovered and vaccinated

Hoffmann summarized the results of the study: "Our research shows that this virus variant can more effectively infect lung and intestinal cells, which indicates that the virus has enhanced adaptability

"In order to prevent the further spread of the B.

###